1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Aditxt Acquires Evofem

M&A Deal Summary

Aditxt Acquires Evofem

On December 12, 2023, Aditxt acquired life science company Evofem for 100M USD

Acquisition Highlights
  • This is Aditxt’s 2nd transaction in the Life Science sector.
  • This is Aditxt’s largest (disclosed) transaction.
  • This is Aditxt’s 2nd transaction in the United States.
  • This is Aditxt’s 1st transaction in California.

M&A Deal Summary
Date 2023-12-12
Target Evofem
Sector Life Science
Buyer(s) Aditxt
Deal Type Add-on Acquisition
Deal Value 100M USD

Target

Evofem

San Diego, California, United States
Evofem develops and anticipates commercializing innovative products that support and promote women as the primary healthcare consumers. It is currently identifying and developing new and novel products that specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections, and products that address or promote general health and wellbeing. Evofem is headquartered in San Diego, California.

Search 215,058 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Aditxt

Richmond, Virginia, United States
Category Company
Founded 2017
Sector Life Science
Employees26
Revenue 1M USD (2022)
DESCRIPTION

Aditxt is developing technologies focused on improving the immune system's health through immune monitoring and reprogramming. Aditxt was founded in 2017 and is based in Richmond, Virginia.

DEAL STATS #
Overall 2 of 4
Sector: Life Science M&A 2 of 4
Type: Add-on Acquisition M&A Deals 2 of 3
State: California M&A 1 of 1
Country: United States M&A 2 of 3
Year: 2023 M&A 1 of 1
Size (of disclosed) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-28 AiPharma Group

Richmond, Virginia, United States

AiPharma Group is a commercial-stage biopharmaceutical company focused on developing oral therapies to address the unmet medical needs of patients with life-threatening viral diseases. Leveraging a deep understanding of antiviral drug development, nucleotide chemistry, biology, biochemistry, and virology. AiPharma Group is based in Richmond, Virginia.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2024-01-30 Brain Scientific - portfolio of EEG brain monitoring technologies and devices

United States

Brain Scientific's portfolio of EEG brain monitoring technologies and devices includes 16 patents, with the flagship products being a disposable NeuroCap and portable NeuroEEG, intended to enable neurologists to streamline their processes by enhancing throughput, increasing patient comfort, and mitigating contamination risks.

Buy -
Mergr

Solution for

Product

Company

Legal